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ABSTRACT 
Adherence of bacteria to biotic or 
abiotic surfaces is a prerequisite for host 
colonization and represents an important step in 
microbial pathogenicity. This attachment is 
facilitated by bacterial adhesins at the cell 
surface. Due to their size and often elaborate 
multi-domain architectures, these polypeptides 
represent challenging targets for detailed 
structural and functional characterization. The 
multifunctional fibrillar adhesin CshA, which 
mediates binding to both host molecules and 
other microorganisms, is an important 
determinant of colonisation by Streptococcus 
gordonii, an oral commensal and opportunistic 
pathogen of animals and humans. CshA binds 
the high-molecular-weight glycoprotein 
fibronectin (Fn) via an N-terminal non-repetitive 
region, and this protein-protein interaction has 
been proposed to promote S. gordonii 
colonization at multiple sites within the host. 
However, the molecular details of how these two 
proteins interact are yet to be established. Here we 
present a structural description of the Fn binding 
N-terminal region of CshA, derived from a 
combination of X-ray crystallography, SAXS, 
and complementary biophysical methods. In 
vitro binding studies support a hitherto 
unreported two-state ‘catch-clamp’ mechanism 
of Fn binding by CshA, in which the disordered 
N-terminal domain of CshA acts to ‘catch’ Fn, 
via formation of a rapidly assembled but also 
readily dissociable pre-complex, enabling its 
neighbouring ligand binding domain to tightly 
‘clamp’ the two polypeptides together. This 
study presents a new paradigm for target binding 
by a bacterial adhesin, the identification of 
which will inform future efforts towards the 
development of anti-adhesive agents that target S. 
gordonii and related streptococci. 
 
 
The adherence of bacteria to material and 
host cell surfaces is essential for colonisation, 
persistence, and pathogenicity. This process is 
facilitated by bacterial cell-surface components 
termed adhesins, which recognise and bind 
specific partner molecules presented on the 
surfaces of host cells and other microorganisms 
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(1). The filamentous adhesins, comprising pili and 
fibrils, are amongst the largest and most complex 
of all bacterial surface proteins. They are found in 
both Gram-positive and Gram-negative bacteria, 
including many pathogenic species, and have 
attracted considerable attention due to their roles 
in colonisation, infection, and as vaccine 
candidates (2,3). Characteristically these proteins 
form sizeable polymeric assemblies that project 
outwards from the bacterial cell surface, 
presenting an adhesive target-binding region at 
their tip. 
Fibrillar adhesins are expressed by a wide 
variety of bacteria and display an extraordinarily 
diverse array of adhesive functions. In contrast to 
the extensively studied pili, much still remains to 
be learned about the structures and functions of 
these proteins. Fibrillar adhesins usually comprise 
a single multi-domain polypeptide chain, 
covalently tethered to the bacterial cell wall (1). 
They frequently display exquisite selectivity for 
their partner ligands, with their modular 
architectures providing a platform for multi-
functionality (4-6). Although smaller than pili, 
they are inherently more complex, with divergent 
molecular structures, functions and adhesive 
properties (7-9).  
Streptococcus species produce a multitude 
of fibrillar adhesins that promote binding to host 
cells and other microorganisms. These include, 
amongst others, the M proteins of Streptococcus 
pyogenes and the antigen I/II family polypeptides 
(10-12). S. gordonii, a primary coloniser of the 
human oral cavity and an opportunistic pathogen, 
has been shown to present a number of fibrillar 
adhesins on its surface, including the polypeptide 
CshA. In vitro and in vivo binding assays, gene 
disruption experiments, and heterologous 
expression studies in the non-adherent bacterium 
Enterococcus faecalis have established CshA as an 
important determinant of S. gordonii adherence 
(4,13). This protein has been shown to play a role 
in binding both to host molecules and a range of 
other microorganisms (14).  
CshA is a 259 kDa polypeptide (4,13) that 
forms ~60 nm peritrichous fibrils on the surface of 
S. gordonii (4). It shares <10 % overall sequence 
identity to any protein of known structure, 
indicative of divergent or novel function. The 
CshA pre-protein is comprised of 2508 amino acid 
(aa) residues, organised in the form of a leader 
peptide (residues 1-41), a non-repetitive region 
(residues 42-778), 17 repeat domains (R1-R17, 
each ~101 aa residues), and a C-terminal cell wall 
anchor (13). CshA has been shown to bind the 
high molecular weight glycoprotein fibronectin 
(Fn) via an interaction that is mediated by the N-
terminal non-repetitive region of the protein (7). 
Antibodies specific to this portion of CshA block 
Fn binding, whilst those raised against the repeat 
domain region elicit no effect (15). The CshA-Fn 
interaction has been proposed to be of general 
significance in promoting S. gordonii colonisation 
at a range of sites within the host (7,15,16). These 
include the cardiac endothelium, where adherence 
by S. gordonii is known to promote the onset of 
infective endocarditis, a severe, potentially fatal 
inflammation of the inner tissues of the heart (17).  
Despite the importance of CshA, little is 
known about the molecular structure and function 
of this protein. Such information would provide 
fundamental mechanistic insight and may inform 
the development of anti-adhesive agents that target 
S. gordonii and related streptococci.  
Here we report a structural and functional 
description of the non-repetitive Fn-binding region 
of CshA. We reveal that this part of the 
polypeptide is composed of three distinct domains, 
designated herein as non-repetitive domain 1 
(NR1, CshA42-222), non-repetitive domain 2 (NR2, 
CshA223-540), and non-repetitive domain 3 (NR3, 
CshA582-814). In vitro Fn-binding assays of 
truncated CshA proteins heterologously expressed 
on the surface of the non-adherent bacterium 
Lactococcus lactis demonstrate that both NR1 and 
NR2, but not NR3, confer adhesive properties to 
CshA. Biolayer interferometry analysis of Fn 
binding by recombinant CshA NR domains reveals 
that NR2 binds both cellular and plasma 
fibronectin with a significantly lower ka, kd, and KD 
than NR1. Using circular dichroism (CD) 
spectroscopy, small angle X-ray scattering 
(SAXS), and allied biophysical methods, NR1 is 
shown to constitute a discrete intrinsically 
disordered domain (IDD). The crystal structure of 
NR2 is also presented, which adopts a lectin-like 
fold with a clearly identifiable ligand binding site. 
Together, our data are consistent with a two-state 
mechanism of Fn binding by CshA, where NR1 
functions to recognise and bind Fn, forming a 
dissociable pre-complex, which is subsequently 
stabilised by a high affinity binding interaction 
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mediated by NR2. This ‘catch-clamp’ mechanism 
of Fn binding may be of general significance in 
other bacterial adhesins that contain intrinsically 
disordered domains.  
 
RESULTS 
Reassignment of CshA Domain 
Architecture 
CshA has previously been shown to comprise four 
distinct regions; an N-terminal signal peptide, a 
>80 kDa non-repetitive region, seventeen ~100 aa 
residue repeat domains, and a C-terminal cell wall 
anchor. In an effort to provide a more detailed 
description of the domain architecture of CshA, 
the sequence of this polypeptide was subjected to 
comprehensive bioinformatic analysis. Predictions 
of secondary and tertiary structure, disorder 
content, domain composition, and homology 
modelling of selected regions of the protein were 
performed. Our reassigned CshA domain 
composition is summarised in Figure 1. The most 
significant consequence was assignment of the 
non-repetitive region of CshA into three distinct 
domains, designated NR1 (CshA42-222), NR2 
(CshA223-540) and NR3 CshA582-814).  
 
 Fn Binding by CshA is Confined to the 
NR1 and NR2 Domains 
In previous studies, CshA has been shown to 
promote adherence by S. gordonii DL1 to the 
extracellular matrix protein Fn, an interaction 
mediated by the non-repetitive region of the 
protein (7,14).  To determine which of the NR 
domains of CshA contribute to Fn binding, full 
length CshA (Fl_CshA) and two truncated forms 
of the protein, CshAΔNR1 and CshAΔNR1+2, 
were expressed on the surface of the non-adherent 
bacterium L. lactis. Genes encoding full length 
CshA, CshAΔNR1 and CshAΔNR1+2, were 
cloned into the pMSP7517 shuttle vector (18) and 
transformed into wild type L. lactis by 
electroporation. Constructs encoding the two 
CshA deletion mutants included the wild type 
CshA leader peptide sequence fused to their N-
termini to ensure efficient export from the 
cytoplasm. 
Levels of surface-expressed CshA 
polypeptides were determined by dot immunoblot 
analysis of S. gordonii DL1, L. lactis MG1363, 
and L. lactis strains expressing Fl_CshA, 
CshAΔNR1, or CshAΔNR1+2. Blots were probed 
with antibodies raised against the repetitive region 
of the protein (Figure 2A). There was no reactivity 
of the CshA antiserum with the L. lactis MG1363 
control. However, S. gordonii DL1 and each of the 
three L. lactis strains engineered to express CshA 
proteins presented the respective polypeptides on 
their surfaces. Variations in the levels of CshA 
surface expression were observed in each of the 
different strains, with Fl_CshA produced in 
greater amount than CshAΔNR1 or CshAΔNR1+2 
(Figure 2A).  
 To measure the relative binding properties 
of heterologously-expressed Fl_CshA, 
CshAΔNR1 and CshAΔNR1+2, the ability of 
lactococci expressing each of these proteins to 
adhere to immobilised human cellular Fn (cFn) 
was assessed (Figure 2B). Levels of adherence 
were compared to those of wild-type S. gordonii 
DL1 and non-CshA expressing L. lactis MG1363. 
Expression of full length CshA on the surface of L. 
lactis conferred the ability to bind cFn. L. lactis 
cells expressing CshAΔNR1 were ~2 fold more 
adherent to cFn than L. lactis::Fl_CshA, 
suggesting that exposure of NR2, by deletion of 
NR1, promotes target binding by CshA. L. lactis 
cells expressing CshAΔNR1+2 bound cFn at a 
level not significantly greater (as established by 
analysis of variance) than L. lactis MG1363, 
suggesting that the NR3 domain is dispensable for 
cFn binding.  
 
Kinetics of Fn Binding by Recombinant 
CshA NR Domains 
To further probe the Fn binding properties of 
CshA NR domains, each of NR1, NR2, and NR3 
were recombinantly overexpressed in Escherichia 
coli and purified to homogeneity (>95% purity). 
Recombinant NR2 was isolated as a mixture of 
monomeric (~70% of total material) and dimeric 
(~30% of total material) species that could be 
readily separated by size-exclusion 
chromatography. Concentration of monomeric 
NR2 by ultrafiltration failed to yield the dimeric 
species, suggesting that NR2 dimerisation is 
concentration independent. Given this, and the 
absence of any prior experimental evidence to 
support homodimerisation of the CshA non-
repetitive region (4,13), monomeric NR2 was 
taken to be the biologically relevant form of the 
protein and was used in all subsequent Fn-binding 
studies.  
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 The kinetics of human cFn and plasma Fn 
(pFn) binding by recombinant CshA NR domains 
were determined by Biolayer interferometry (Blitz, 
ForteBio). Both cFn and pFn were analysed as 
they share many structural features and functional 
properties, but are synthesised by different cell 
types and at different locations. Fn proteins were 
amide coupled to the tip surface of amine reactive 
second-generation (AR2G) biosensors (Fortebio) 
prior to analysis. Binding affinities were measured 
between each of the two Fn proteins and NR1, 
monomeric NR2, and NR3; the control proteins 
BSA and CshA repeat domain 13 (R13); and a 
commercially sourced anti-Fn antibody (Dako; 
Figure 3). The R13 domain of CshA was chosen 
for analysis as unlike other repetitive domains of 
the polypeptide, recombinant protein could be 
readily produced in high quantity. Experimentally 
determined kinetic parameters for cFn and pFn 
binding are summarised in Table 1. Neither BSA 
nor CshA R13 bound either form of Fn. By 
contrast, the anti-Fn antibody bound both 
substrates with an equilibrium dissociation 
constant (KD) in the low µM range (Table 1). 
Recombinant NR1 bound both cFn and pFn with 
KD approximately twice that of the anti-Fn 
antibody. This confirms that NR1 binds cFn and 
pFn but with lower affinity than the anti-Fn 
antibody. NR2 was found to bind cFn and pFn 
with a >10 and >4 fold lower KD respectively than 
NR1, and a >5 and >2 fold lower KD respectively 
than the anti-Fn antibody. These data demonstrate 
that NR2 binds Fn with high affinity, an 
observation in keeping with our heterologous 
expression studies, where deletion of NR1 serves 
to promote adherence to cFn by L. lactis strains. 
Kinetic parameters for Fn binding by CshA NR1 
and NR2 suggest that NR1 forms a rapidly 
assembled (higher ka) but readily dissociable 
(higher kd) complex with Fn, whereas substrate 
binding by NR2 occurs over a longer timescale 
(lower ka), yielding a less rapidly dissociating 
complex (lower kd). Although there is variation in 
the kinetic parameters of cFn and pFn binding by 
individual CshA domains, the relative binding 
properties of each domain are consistent 
irrespective of the form of Fn used. NR3 is found 
to bind both cFn and pFn weakly, confirming a 
negligible role in defining the adhesive properties 
of CshA.  
 
CshA NR1 is a Discrete, Intrinsically 
Disordered Domain 
Inspection of the aa sequence of the NR1 domain 
of CshA reveals that this protein is rich in 
disorder-promoting residues (10% Pro, 11% Glu 
and 12% Ser) and deficient in order-promoting 
residues (<5% Ile and Leu, with no Cys, Phe, Trp, 
or Tyr). Analysis of the NR1 sequence using 
PONDR-FIT (19) suggests that >95% of NR1 is 
structurally disordered (Figure 4A). To determine 
whether NR1 is indeed an intrinsically disordered 
domain (IDD), the protein was subjected to 
biophysical and hydrodynamic characterisation. 
Recombinant NR1 displays aberrant migratory 
behaviour when analysed by SDS-PAGE, 
characteristic of intrinsic disorder (20). The 
protein migrates with an apparent molecular mass 
of ~37 kDa (Figure 4B), although possesses an 
experimentally verified mass of 20.8 kDa 
(including hexahistidine-tag and linker; data not 
shown). Similarly, the CD spectrum of the protein 
is consistent with an absence of secondary 
structure, with a single minimum centered around 
200 nm and no strong negative signals above 205 
nm (Figure 4C). Deconvolution of this spectrum 
employing the CDSSTR algorithm (21) and 
reference sets 6 and 7 (22,23) gives a predicted 
disorder content of 79-81%.  
To further investigate the structure of NR1 
this protein was analysed by SAXS, a technique 
that is widely recognised as indispensable for the 
assignment and characterisation of IDDs (24). 
SAXS data were processed to yield Guinier and 
Kratky plots, and to calculate the shape and size of 
NR1 (Figure 4D). The Guinier plot is linear in Q2 
in the low angle region confirming that 
recombinant NR1 is monodisperse in solution 
(data not shown). Analysis of the Guinier region 
(RgQ <1.3) yields a radius of gyration of ~67 Å, 
consistent with an extended conformation in 
solution. The Kratky plot derived from the NR1 
scattering curve contains a distinct peak indicative 
of globular structure; however, the data do not 
progress to zero at high Q, suggestive of 
significant disorder content. Calculated 
dimensions of NR1 reveal an elongated structure 
of ~250 Å x ~70 Å in size, consistent with a 
loosely compacted but predominantly disordered 
structure. This contrasts with theoretically 
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calculated dimensions of ~560 Å x ~2 Å for the 
fully disordered polypeptide. 
 
Crystallisation and Structure 
Determination of NR2 
Having established that NR1 is an IDD, we next 
turned our attention to the NR2 domain of CshA. 
Both monomeric and dimeric forms of this protein 
were subjected to crystallisation screening. 
Monomeric NR2 proved recalcitrant to 
crystallisation; however, dimeric NR2 was readily 
crystallisable. The structure of this protein was 
determined to 2.7 Å resolution in space group 
P6222 using the single wavelength anomalous 
dispersion (SAD) method as applied to 
selenomethionine (SeMet) labelled crystals of 
dimeric NR2. The asymmetric unit comprises two 
copies of NR2, each of which form a strand-
swapped homodimer with a partner monomer from 
a neighbouring asymmetric unit (Figure 5A). 
Compelling electron density was not observed for 
the residues comprising the vector encoded His6-
tag and cleavable linker, and the residues 313-331, 
393-397, and 488-560 in either of the two copies 
of NR2. These residues have consequently been 
omitted from our final model. Inspection of the 
NR2 strand-swapped dimer reveals that each of 
the two monomers buries its three C-terminal β-
strands (residues 447-488) into the central core of 
its dimer partner (Figure 5A). Such extensive 
strand-swapping is unusual even in entirely β-
strand proteins (25). In Fl_CshA, the N and C 
termini of NR2 are tethered to their neighbouring 
NR1 and NR3 domains respectively, an 
organisation that would disfavour NR2 strand-
swapping. Further, previous studies of 
heterologously expressed Fl_CshA have revealed 
no evidence of dimer, or higher oligomer 
formation (4, 13). Together these observations 
imply that the observed dimerisation is an artefact 
of protein over-expression. This provides further 
support for the validity of conducting our in vitro 
binding assays with monomeric recombinant NR2.  
 
NR2 is a Discrete Ligand Binding Domain 
with a Lectin-Like Fold 
Based on our NR2 strand-swapped dimer crystal 
structure a model of the biologically relevant 
monomeric form of the protein was produced 
(Figures 5B and 5C). Inspection of this model 
reveals a globular protein with a lectin-like fold, 
comprising a β-sandwich core decorated with α-
helices. The sandwich is formed from two anti-
parallel β-sheets of four and five strands 
respectively, with the interface between the two 
sheets populated by predominantly hydrophobic 
amino acids. The β-sandwich is augmented by a 
series of short α-helices co-located at one end of 
the protein, which pack against strands 5, 7 and 
10. The model suggests that the residues 313-331, 
for which compelling electron density was not 
observed in the NR2 dimer crystal structure, form 
a large flexible loop that caps a highly negatively 
charged pocket on the surface of the protein 
(Figures 5B and 5C). Given the absence of any 
other cavities, clefts, or highly charged surfaces, it 
is likely that this pocket constitutes the ligand 
binding site of NR2.  
 
Identification of Structural Relatives of 
NR2 Supports a Role in Carbohydrate Binding 
Despite minimal sequence identity to any protein 
of known structure, a DALI search using 
monomeric NR2 identifies a number of 
structurally related proteins. These include the N1 
region of the S. gordonii adhesin Sgo0707 (Z-
score = 8.9; (26)), the adhesive V domains of the 
antigen I/II polypeptides SspB (Z-score = 7.1; 
(27)) and SpaP (Z-score = 7.0; (28)), and the endo-
β-1,4-galactanase TmCBM61 from Thermotoga 
maritima (Z-score = 5.8 (29). Structural identity 
between NR2 and its relatives is predominantly 
restricted to the β-sandwich core of the protein, 
with significant divergence in the extent and 
identity of structural elements that decorate this 
sub-assembly (Figure 6). Each of the structural 
homologues identified are involved in binding 
carbohydrates or glycoproteins, and with the 
exception of TmCBM61, act as the adhesive 
component of a cell wall-anchored polypeptide in 
a Gram-positive bacterium.  
 
DISCUSSION 
In previous studies we have established 
the important role played by the S. gordonii cell 
wall-anchored polypeptide CshA in mediating 
adherence to host and microbial cell surfaces 
(4,7,14,15). Here we extend the scope of our 
investigations to include detailed molecular level 
characterisation of the Fn-binding ‘non-repetitive 
region’ of this protein. This portion of CshA 
possesses an aa sequence distinct from that of any 
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polypeptide for which structural or functional 
studies have been conducted to date, indicative of 
novel form or function.  
In vitro cFn-binding assays of 
heterologously-expressed wild type CshA and 
truncated variants thereof confirm the critical role 
played by the non-repetitive region of CshA in 
facilitating cFn binding. These data also 
demonstrate that the adhesive properties of CshA 
are confined to the NR1 and NR2 domains of the 
protein. Surprisingly, a CshAΔNR1-expressing 
strain of L. lactis is more adherent to immobilised 
cFn than that expressing the wild type polypeptide. 
These data imply a mechanism of Fn binding by 
CshA where NR2 forms a dominant, tight-binding 
interaction with its Fn substrate.  
Results from complementary experiments 
investigating the kinetics of Fn binding by 
recombinant NR proteins are consistent with our 
heterologous expression studies. NR1 is found to 
bind both cFn and pFn with a KD in the low µM 
range. NR2 binds both forms of Fn with greater 
affinity than NR1, demonstrating that this domain 
forms a stable, less dissociable interaction with Fn 
than its NR1 neighbour. Conversely, NR1 exhibits 
both a ka and kd for c/pFn greater than that of NR2, 
indicating that NR1 engages and disengages Fn 
more rapidly. NR3, which was found to be 
dispensable for Fn binding in our heterologous 
expression studies, is shown using the BLitz 
technique to bind cFn and pFn only weakly, 
indicating that this domain may not significantly 
contribute to Fn binding in vivo. Together our data 
are consistent with a mechanism of Fn binding by 
CshA that involves a rapidly formed but readily 
dissociable NR1-Fn complex, in tandem with a 
higher affinity, but less frequently formed NR2 
dependent interaction.  
To further probe the mechanism of Fn 
binding by CshA, recombinant NR1 and NR2 
were subjected to structural characterisation. NR1 
is shown to exhibit all the hallmarks of an IDD, 
including aberrant hydrodynamic behaviour and 
an absence of secondary structure (20,30). SAXS 
analysis of NR1 demonstrates that the protein 
adopts a disordered but partially compacted 
structure in solution. Such a conformation is 
typical of IDDs, which form loosely assembled 
dynamic structures, stabilised by residual local and 
long-range weak intramolecular forces (31). This 
results in inherent conformational adaptability, and 
in the case of IDDs that are involved in protein or 
ligand binding, confers an expanded capture 
radius, enabling target binding over greater 
distances than can be achieved by globular 
proteins (32). Target engagement by IDDs may be 
concomitantly accompanied by partial or complete 
recovery of a fold state, a process which often 
brings both partners into closer proximity, 
potentially enhancing the rate of binding by the so-
called ‘fly-casting’ mechanism (33). Given that 
the energy needed to recover secondary structure 
is abstracted from the interaction energy of 
binding, IDDs generally form low affinity 
interactions with their binding partners, 
characterised by remarkably fast on- and off-rates 
(34). Fn binding by NR1 exhibits many of these 
defining characteristics, including rapid complex 
formation and dissociation, and a weak yet 
specific relative binding affinity. Interestingly, 
NR1 is devoid of sequence motifs that have been 
previously implicated in IDD-mediated bacterial 
adherence to cell surface molecules, implying that 
Fn binding by CshA NR1 may proceed via a 
mechanism that is distinct from, for example, the 
tandem β-zipper model (35). There was no 
evidence of NR1-NR2 complex formation, as 
assessed by native PAGE, when the two domains 
were mixed in vitro, implying that NR2 does not 
bind NR1 and act to template its folding. 
In contrast to NR1, the NR2 domain of 
CshA is shown to adopt a globular structure with a 
lectin-like fold. The protein presents a clearly 
identifiable ligand-binding site on its surface that 
is populated by a combination of aromatic and 
negatively charged residues. This composition is 
consistent with a role for NR2 in the binding of 
carbohydrates or glycoproteins, a function further 
supported by our in vitro binding data, and the 
identification of structural homologues of NR2 
that mediate protein-carbohydrate interactions (26-
29,36). The ligand-binding site of NR2 is capped 
by a sizeable loop, for which no electron density 
was observed during structure elucidation. The 
absence of compelling electron density in this 
region is indicative of flexibility. It therefore 
appears likely that the capping loop plays a role in 
gating access to the NR2 binding site, potentially 
acting to expose this highly charged pocket during 
Fn engagement. Based on available structural and 
functional data it is not possible to unambiguously 
identify the specific glycosylation(s) upon Fn that 
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are bound by NR2, though this represents a major 
focus for future investigations. 
In summary, we report herein a structural 
and functional dissection of the Fn-binding, non-
repetitive region of the S. gordonii fibrillar adhesin 
CshA. Uniquely, CshA appears to employ a 
bipartite mechanism of target binding that involves 
the coordinated action of a low affinity but high 
capture radius IDD, in partnership with a high-
affinity, high-specificity ligand binding domain. 
Our data suggest a two-step ‘catch-clamp’ Fn-
binding mechanism, wherein the disordered NR1 
domain of CshA acts to engage and ‘catch’ Fn, via 
a process that is expedited by its elongated, 
disordered conformation. The resulting NR1-Fn 
pre-complex is rapidly formed and dissociated, 
though may be stabilised via an NR2-mediated 
tight binding interaction, which functions to 
‘clamp’ CshA and Fn together (Figure 7). Such a 
mechanism offers an elegant solution to the 
problem of forming highly specific intermolecular 
interactions within molecularly rich environments 
such as the human host. A number of fibrillar 
adhesins have been identified that incorporate 
IDDs, and as such the ‘catch-clamp’ mechanism 
outlined herein may be of general applicability to 
other bacterial surface proteins that possess such 
domains (37). Finally, the unusual target binding 
mechanism exhibited by CshA, along with 
molecular insights provided herein, presents a 
framework for the development of new anti-
adhesive interventions that target disease causing 
streptococci and related bacteria. Such 
interventions could be based on multicomponent 
agents that target both the IDD and ligand-binding 
steps during adherence. 
 
EXPERIMENTAL PROCEDURES 
Bioinformatic Analysis and Reassignment 
of CshA Domain Architecture 
Bioinformatic analysis and homology modelling 
studies were performed using non-proprietary 
software or publicly accessible web servers. In 
cases where the CshA amino acid sequence was 
too long for analysis, the protein sequence was 
sub-divided into appropriately sized regions and 
each analysed independently. Domain composition 
of CshA and the identification of domain 
boundaries was performed using Interpro (38) 
integrating 11 databases including Pfam (39), 
PRINTS (40), PROSITE (41) and ProDom (42), to 
provide prediction of protein families and 
domains. Complementary analyses were 
performed using the DomPred server (43). 
Disorder prediction was performed using PONDR-
FIT (19), secondary structure prediction performed 
using PSIPRED (44), signal peptide prediction 
performed using RPSP (45), and the presence of 
coiled-coils was established using COILS (46). 
Where a suitable template or templates could be 
identifies, SWISS-MODEL (47-50) or PHYRE2 
(51) were used to generate homology models of 
identified CshA domains to allow more accurate 
assignment of domain boundaries. 
 
Bacterial Strains and Growth Conditions 
S. gordonii DL1 (Challis) (52) was routinely 
cultured in BHY broth [3.7% Brain-Heart infusion 
(LabM), 0.5% yeast extract (Bacto)], anaerobically 
at 37°C. L. lactis MG1363 was cultured in GM17 
broth [3.72% M17 (Difco), 0.5% glucose] at 30°C 
under anaerobic conditions. Cultures of L. lactis 
expressing CshA, CshAΔNR1 or CshAΔNR1+2 
were supplemented with 5 µg/ml erythromycin.  E. 
coli Gigasingles (EMD Millipore) and BL21 were 
cultured in LB broth [2.5% Luria-Bertani (Fisher 
Scientific)] at 37°C with shaking at 200 r.p.m., 
supplemented with 50 µg/ml  carbenicillin.  
 
Generation of L. lactis Heterologous 
Expression Strains 
Plasmids (Table 2) or PCR amplicons were 
purified using QIAquick Spin Miniprep or PCR 
Purification kits respectively (Qiagen). 
Oligonucleotides were synthesised by MWG 
Eurofins. Chromosomal DNA was extracted from 
S. gordonii DL1 as described previously (53). 
Unless otherwise stated, DNA was PCR-amplified 
with PrimeSTAR GXL DNA polymerase 
(Clontech). Primers pMSP-cshA.F/R (Table 2) 
were designed to amplify the entire cshA gene 
from S. gordonii DL1 chromosomal DNA, 
incorporating unique NcoI/XhoI restriction 
endonuclease sites at its termini. The purified 
amplimer was cloned into vector pMSP7517 (18) 
using ligation-independent In-Fusion HD Cloning 
kit (Clontech). The resultant construct 
(pMSP::cshA) was transformed into competent E. 
coli Stellar™ cells (Clontech), recovered, and 
confirmed by sequencing. This construct was 
employed as template for in-frame deletion of 
NR1 (primers cshA.Rev2/Fwd2) or NR1+2 
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(primers cshARev.primerA/ cshAFwd.primerB) 
from cshA, based upon a circular PCR method 
(54) with 5’ phosphorylated primers. Following 
PCR amplification with Phusion High-Fidelity 
DNA polymerase (NEB), template was removed 
by DpnI digestion, and purified amplimers were 
self-ligated using T4 DNA ligase. Constructs were 
transformed into E. coli Stellar™ cells, and 
confirmed by sequencing. Consequently the three 
pMSP-derived constructs were electroporated into 
L. lactis MG1363, as described previously (55). 
Transformants were recovered on GM17 agar 
supplemented with erythromycin, and expression 
of CshA, CshAΔNR1 or CshAΔNR1+2 on the 
surface of L. lactis was verified by SDS-PAGE 
and Western immunoblot analyses. 
 
 Western Immunoblot Analysis 
Expression of CshA, CshAΔNR1 or 
CshAΔNR1+2 on the surface of L. lactis was 
induced by culturing cells in the presence of 10 ng 
nisin/ml. Suspensions were adjusted to OD600nm 1.5 
and spotted (2 µl) onto nitrocellulose membrane. 
The membrane was blocked with TBS (50 mM 
Tris-HCl, pH 7.6, 0.15 M NaCl) containing 10% 
(w/v) milk powder, and subsequently probed with 
rabbit α-CshA-RR (15) followed by swine anti-
rabbit IgG-horseradish peroxidase (HRP) 
conjugate (Dako), both diluted 1 in 1000 into TBS 
supplemented with 0.1% Tween-20 and 1% milk 
powder. The membrane was then developed using 
AmershamTM ECLTM Western Blotting Analysis 
System (GE Healthcare) according to 
manufacturer’s instructions.  
 
Cell Binding Assays 
Human cFn (Sigma) was diluted in coating buffer 
[20 mM Na2CO3, adjusted to pH 9.3 with 
NaHCO3] and adsorbed onto microtiter plate wells 
(Immulon 2HB) for 16 h at 4°C. Non-specific 
binding sites were blocked with 3% BSA 
containing 0.05% Tween, and the wells were 
washed with TBSC (10 mM Tris-HCl pH 7.6, 150 
mM NaCl, 5 mM CaCl2). Bacterial cells in TBSC 
(5 x 108 cells/ml) were added to wells (0.1 ml) and 
incubated for 2 h at 37°C. Adhered cells were 
fixed, stained with crystal violet and biomass 
quantified by measuring A595 (8).  
 
Gene Cloning 
DNA fragments corresponding to CshA42-222 
(NR1), CshA223-540 (NR2), CshA582-814 (NR3), and 
CshA1032-2130 (R13) were PCR amplified from 
either plasmid pAM401::cshA (4) or S. gordonii 
DL1 chromosomal DNA using primers listed in 
Table 2. PCR products were ligated into vector 
pOPINF (56) using the In-FusionTM system 
(Clontech). Resulting plasmids encoded N-
terminally hexa-histidine tagged CshA domains. 
All constructs was verified by DNA sequencing. 
 
Protein Expression and Purification  
E. coli BL21 (DE3) cells harbouring CshA domain 
expression plasmids were grown in LB medium 
supplemented with carbenicillin at 37°C to A600 = 
0.4-0.6. Protein expression was induced by adding 
IPTG (1 mM) and incubating cultures for 16 h at 
18°C. Bacteria were harvested by centrifugation, 
suspended in 20 mM Tris-HCl, 150 mM NaCl, pH 
8 and lysed with a cell disruptor (Z Plus Series cell 
disruptor, Constant Systems Ltd) at 25 kpsi. Cell 
supernatants were applied to a 5 ml Hi-Trap 
chelating column (pre-loaded with nickel, GE 
Healthcare) and eluted with an imidazole gradient 
(10–500 mM) over 15 column volumes. Fractions 
containing CshA proteins were pooled, 
concentrated and further purified by passage 
through a Hi-Load 16/60 Superdex 75 column (GE 
Healthcare) pre-equilibrated in 20 mM Tris-HCl, 
150 mM NaCl, pH 7.5. Fractions containing CshA 
proteins were pooled and concentrated by 
ultrafiltration to 10 mg/ml.  
For the production of selenomethonine labelled 
NR2 a culture of E. coli BL21 (DE3) cells 
harboring pOPINF:cshA-NR2 was grown in LB 
medium supplemented with carbenicillin  at 37°C 
for 16 h. Cells were harvested by centrifugation, 
washed three times, suspended in double-distilled 
water, and used to inoculate 1 L SelenoMetTM 
medium (Molecular Dimensions Ltd) containing 
carbenicillin, supplemented with SelenoMet 
Nutrient Mix (Molecular Dimensions Ltd). The 
culture was grown at 37°C with shaking to A600 = 
0.6. A mix of amino acids was added to the culture 
(100 mg lysine, 100 mg phenylanlanine, 100 mg 
threonine, 50 mg isoleucine, 50 mg leucine, 50 mg 
valine, 60 mg selenomethionine), which was then 
incubated with shaking, for 15 min, at 37°C. IPTG 
was added (final concentration 1 mM) and the 
culture incubated for 16 h at 18°C. Cells were 
harvested and processed for protein purification as 
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above with the addition of 2 mM tris(2-
carboxyethyl)phosphine TCEP to all 
chromatography buffers. 
 
Mass Spectrometry 
For accurate intact mass determination a sample of 
recombinant CshA NR1 with His-tag intact was 
prepared. Mass analysis was performed using an 
UltrafleXtreme mass spectrometer (Bruker 
Daltonik) in positive, reflectron ion mode.  Data 
analysis was performed using the Bruker flex 
Analysis software. 
 
Biolayer Interferometry  
The BLItz® system (Fortebio) was used to 
measure binding affinity and kinetics of the 
interaction between cFn or pFn with CshA 
recombinant protein fragments. All experiments 
were performed at 20 oC, using PBS-based (pH 
7.4) Kinetics Buffer (ForteBio). c/pFn were 
immobilized onto Dip and Read™ Amine 
Reactive Second-Generation (AR2G) Biosensors 
using N-hydroxysuccinimide/1-ethyl-3-
(3dimethylaminopropyl)carbodiimide 
(NHS/EDC)-catalysed amide bond formation at 20 
µg/ml in 10 mM acetate buffer pH 4.0 for 5 min. 
Probes were quenched in 1 M ethanolamine pH 
8.5 and used for kinetic assays of CshA protein 
activities. The association and dissociation kinetics 
of the CshA proteins were performed at 
concentrations of 5, 15, 25 and 50 µM. The kinetic 
dataset was globally fitted employing a 1:1 
binding model. 
 
CD Spectroscopy 
CD spectra of 1 mg/ml recombinant NR1 in 20 
mM phosphate pH 7.5, 150 mM NaCl, were 
collected using an Aviv model 410 CD 
spectrometer at 20°C, using a 0.05 cm path-length 
cuvette, with a wavelength interval of 1 nm and a 
data collection time of 1 s. The buffer-only 
spectrum was subtracted, and the data were 
converted to mean residue ellipticity. The 
CDSSTR algorithm (22,23) and associated 
reference data sets, were used for data analysis, 
accesssed via the DichroWeb server (21). 
 
Small Angle X-ra Scattering  
SAXS data of CshA NR1 was collected at 
Diamond Light Source (beamline I22) at a 
wavelength of λ = 1 Å and a sample-to-detector 
distance of 2.5 m. Three sample concentrations 
were measured: 8, 4 and 2 mg/ml. Samples were 
exposed for 200 frames of 1 sec. Each frame was 
sector-integrated with in-house beamline software. 
There was no evidence of concentration-dependent 
effects, thus data collected for the 8 mg/ml sample 
of NR1 were used for further analysis. Buffer 
scattering was subtracted using in-house software 
Scientific Data Analysis (SDA) for non-crystalline 
diffraction. Particle distance distribution function 
(p(r)) and maximum intra-particle dimension 
(Dmax) were calculated with GNOM (57). PRIMUS 
(58) was used to calculate the radius of gyration 
(Rg) employing the Guinier approximation and to 
generate a Kratky plot. The shape of the protein 
was evaluated using DAMMIF (59).  
 
Protein Crystallisation  
Conditions supporting the growth of crystals of 
native and SeMet-labelled dimeric CshA NR2 
were initially identified using the hanging drop 
method of vapour diffusion at 20°C and 
commercially available screens. Diffraction 
quality crystals of unlabelled or SeMet-labelled 
CshA NR2 were grown in 0.2 M Na/K tartrate, 20-
25% polyethylene glycol 3350, MMT buffer (DL-
malic acid, MES and Tris base in the molar ratios 
1:2:2), pH 5.0. Crystals selected for diffraction 
data collection were mounted in appropriately 
sized litholoops (Molecular Dimensions Ltd) and 
flash-cooled in liquid nitrogen without additional 
cryoprotection prior to analysis.  
 
Diffraction Data Collection and Structure 
Determination 
Diffraction data were collected at Diamond Light 
Source, UK, on beamlines I03 and I04-1. Data 
were processed with iMosflm (60), and scaled 
with Scala (61) as implimented in the CCP4 suite 
(62). Two sets of CshA_NR2 SeMet-labelled data 
were integrated using iMosflm and scaled with 
Scala. This data was then prepared for merging 
and scaling in Pointless (61,63) and merged with 
Aimless (61,64), to scale together multiple 
observations of reflections. The structure of 
CshA_NR2 was initially determined in space 
group P6222, with two molecules in the 
asymmetric unit, to 3.5 Å resolution, using the 
SAD method as applied to SeMet-labelled crystals 
of dimeric NR2. Identification of heavy atom sites 
Streptococcus gordonii CshA 
 10 
and the resulting initial phase calculation was 
carried out using Phenix Autosol (65). 18 Se sites 
were located with a figure of merit (FOM) of 0.35. 
The output model was refined utilising Refmac5 
and employed as a molecular replacement search 
model to elucidate a higher resolution NR2 
structure (2.7 Å) using PhaserMR (66), employing 
diffraction data collected from a crystal of 
unlabelled NR2. The resulting model was 
subjected to additional cycles of automated model 
building with Phenix AutoBuild (67), followed by 
iterative rounds of manual model building and 
refinement using COOT (68) and Refmac5 (69) 
respectively. Data collection, phasing and 
refinement statistics for CshA NR2 are provided in 
Table 3. Protein structure figures have been 
prepared with PyMOL (Schrödinger, LLC).  
 
Electrostatic Potential Calculations 
For figures showing an electrostatic potential 
projected on the molecular surface of protein 
structures, the Poisson-Boltzmann electrostatic 
potential on the solvent accessible surface is 
shown, with potential values ranging from −15 
kT/e (red) to 15 kT/e (blue). This was calculated 
using the APBS plugin (70) in PyMol, and a PQR 
file generated using PDB2PQR (71), with PARSE 
force-field charges after protonation state 
assignment by PropKa (72,73).  
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The content is solely the responsibility of the authors and does not necessarily represent the official views 
of the NIH. 
 
Atomic coordinates and structure factors for CshA NR2 have been deposited with the PDB with accession 
code 5L2D. 
 
The abbreviations used are: CshA, cell surface hydrophobicity protein A; NR1, non-repeat region 1; R13, 
repeat region 13; IDD, intrinsically disordered domain; SEC, size exclusion chromatography; SeMet, 
selenomethionine; SAD, single anomalous dispersion; SAXS, small angle X-ray scattering; c/pFn, 
cellular/plasma fibronectin; BSA, bovine serum albumin. 
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TABLES 
 
 
 
 
 
 
 
Table 1. Kinetic parameters of (A) cFn and (B) pFn binding by recombinant CshA domains No 
binding was observed between c/pFn and BSA. 
 
cFn Binding      
CshA Domain KD  (µM)  ka (1/Ms) ka Error (1/Ms) kd (1/s) kd Error (1/s) 
NR1 5.26 3.1x10
3
 8.71x10
1
 1.63x10
-2
 9.21x10
-4
 
NR2 0.5 1.38x10
3
 1.35x10
1
 6.89x10
-4
 1.05x10
-5
 
NR3 12.5 8.05x10
2
 2.10x10
1
 1.00x10
-2
 1.34x10
-4
 
Anti-Fn Ab 1.94 6.29x10
3
 2.95x10
2
 1.22x10
-2
 3.61x10
-4
 
pFn Binding      
CshA Domain KD (µM) ka (1/Ms) ka Error (1/Ms) kd (1/s) kd Error (1/s) 
NR1 3.45 9.07x10
3
 6.67x10
2
 3.13x10
-3
 9.11x10
-4
 
NR2 0.85 2.77x10
3
 2.21x10
1
 2.36x10
-3
 2.61x10
-5
 
NR3 9.42 1.33x10
3
 3.73x10
1
 1.27x10
-2
 2.31x10
-4
 
Anti-Fn Ab 1.77 7.09x10
3
 3.48x10
2
 1.25x10
-2
 4.06x10
-4
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Table 2. Plasmids and primers used during this study  
 
Primer name Sequence 5’-3’ Nucleotide no. 
CshA-Head1_fwd aagttctgtttcagggcccgatgGATGAAACAAGCGCTTCTGGTGTTCAA 124-150 
CshA-Head1_rev atggtctagaaagctttactactaGTTAATTTGTTTGGCTAATTGAGTACT 639-666 
CshA-Head2_fwd aagttctgtttcagggcccgatgTGGGTTGATTTTTCTGATACAGCAAGT 666-693 
CshA-Head2_rev atggtctagaaagctttactactaCTCACGGTCATCGGCCGTCCAGTCACT 1594-1620 
CshA-Neck1_fwd aagttctgtttcagggcccgatgAATGGTAATGCCAAGGCCTATGTCAAA 1621-1770 
CshA-Neck2_rev atggtctagaaagctttactactaACCAGTCGAATCGTATTTTGGTACCTT 2416-2442 
CshA-R13_fwd aagttctgtttcagggcccgatgACAGGAACTGGTGCAACTAGCACAGGT 6094-6120 
CshA-R13_rev atggtctagaaagctttactactaTACTTTCGTAAACTCTGGACTGTAGGT 6364-6390 
pMSP-cshA.F GAGGCACTCACCATGGAGGAGGTCATTATGGGAAAAGATTTG -5-15
a 
pMSP-cshA.R GGAGACCGGCCTCGAGATACAGGACAGAAAACCCTTC +1254-+1274
a  
cshA.Rev2 P-TTCATCAGCGCTAACCTG 112-129 
cshA.Fwd2 P-TGGGTTGATTTTTCTGATACAG 667-688 
cshARev.primerA P-TTCATCAGCGCTAACCTGCGTTGC 106-129 
cshAFwd.primerB P-CGTGAGGATGTAGCCGATGAAGGT 1615-1638 
Plasmid name Characteristics Source/Reference 
pOPINF Protein expression vector, incorporating an N-terminal MAHHHHHHSSGLEVLFQGP tag (AmpR) (56) 
pMSP7517 
Contains the E. faecalis prgB gene, encoding aggregation 
substance, downstream of a nisin-inducible promoter PnisA 
(ErmR) 
(18) 
a- are base pairs upstream of cshA gene. + are base pairs downstream of cshA gene. 
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Table 3. Summary of X-ray data collection and refinement statistics 
 
   CshA_NR2  CshA_NR2-SeMeta  
Data collection        
Space group   P6222   P6222  
Cell dimensions         
    a, b, c (Å)  173.93, 173.93, 104.07 172.60, 172.60, 101.85  
Resolution (Å)  61.01-2.66 (2.8-2.66)b  60.13-3.21 (3.43-3.21)  
Rmerge  10.7 (147.7)  26.7 (129.1)  
I / σI  19.8 (2.1)  16.3 (1.1)  
CC1/2 (%) - 90.5 (39.1) 
Completeness (%)  100.0 (100.0)  96.5 (80.7)  
Redundancy  16.8 (16.6)  36.0 (6.6)  
No. Se sites - 18 
FOM - 0.35 
         
Refinement        
Resolution (Å)  61.01-2.66     
No. reflections  25,890     
Rwork / Rfree  19.5/25.2    
No. atoms      
    Protein  7,468     
    Ligand/ion  0      
    Water  2     
B factors Å2     
    Protein   48.0     
    Ligand/ion   -     
    Water   52.3     
r.m.s. deviations        
    Bond lengths (Å)  0.016     
    Bond angles (°)  1.88     
Ramachandran favored (%) 92.8  
Ramachandran outliers (%) 2.3  
aTwo separate CshA_NR2-SeMet crystals were used to collect data. bValues in parentheses are for 
highest-resolution shell. 
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FIGURE LEGENDS 
Figure 1. Reassigned Domain Architecture of CshA 
The CshA polypeptide comprises an N-terminal leader peptide (residues 1-40), a three domain non-
repetitive region (residues 41-819), a repeat region formed from seventeen 90-102 aa domains (residues 
820-2507), and a C-terminal LPxTG cell wall anchor motif. The CshA domains NR1, NR2, NR3, and 
R13, produced recombinantly during this study, are highlighted (masses include vector encoded His6-tag 
and linker). 
 
Figure 2. CshA Dependent Adherence of S. gordonii and L. lactis Strains to Immobilised Cellular 
Fibronectin  
Dot immunoblot analysis of CshA expression levels on the surface of S. gordonii and L. lactis strains. (B) 
Comparative levels of cFn adhesion by S. gordonii and L. lactis strains expressing CshA proteins. Mean 
values from four independent experiments are shown. Error bars represent standard deviations from the 
mean. *P < 0.05, ** P < 0.006 as established by analysis of variance (ANOVA) using Dunett's multiple-
comparison test.  
 
Figure 3. Sensorgrams of Fibronectin Binding by CshA Recombinant Domains and Control 
Proteins  
Representative of the binding of each CshA fragment (NR1, NR2, NR3 and R13), BSA and Fn antibody, 
to either plasma (A) or cellular (B) Fn. Note: the KD values are computationally calculated based on the 
exact amount of Fn deposited on the biosensor tip, which varies from run to run. 
 
Figure 4. Biophysical and Structural Characterisation of CshA NR1 
(A) PONDR-FIT analysis of the CshA NR1 aa sequence. (B) SDS-PAGE analysis of recombinant NR1. 
The predicted molecular mass of the protein based on amino acid composition is 20.8 kDa. (C) Far-UV 
CD spectrum of CshA_NR1. The trace shown is a mean average calculated from ten scans of the same 
protein sample. (D) SAXS scattering profile of CshA NR1. A Kratky plot derived from the scattering 
profile is shown as an inset.  
 
Figure 5. Structural Studies of CshA NR2 
(A) X-ray crystal structure of the CshA NR2 strand-swapped dimer. Individual monomers are coloured 
yellow and purple respectively. The location of loop regions comprising residues 313-331 and 393-397 
for which convincing electron destiny was not observed are indicated by dotted lines. (B) Structural 
model of CshA NR2 based on the strand-swapped dimer crystal structure. The location of the ligand 
binding site and associated capping loop are indicated. (C) Details of the CshA NR2 ligand-binding site 
including electrostatic charge distribution (blue positive, red negative) and aa composition.  
 
Figure 6. Comparison of CshA NR2 with Structurally Related Homologues 
Structures of the N-terminal domain of S. gordonii Sgo0707 (green); the AgI/II polypeptide V domains of 
S. mutans SpaP (orange) and S. gordonii SspB (blue); CshA_NR2 (model based on the strand-swapped 
dimer crystal structure; cyan); and T. maritima TmCBM61 (yellow). The conserved β-sandwich core of 
each protein is highlighted with a blue rectangle. 
 
Figure 7. Cartoon Depicting the Catch-Clamp Mechanism of Fn Binding by CshA 
The intrinsically disordered NR1 domain of the protein rapidly engages and binds Fn in a process 
expedited by the sizeable capture radius of the domain. Fn binding results in the formation of a 
dissociable pre-complex that may be accompanied by the recovery of NR1 secondary structure. The 
resulting pre-complex is stabilised by a high affinity binding interaction mediated by the NR2 domain of 
CshA. 
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Figure S2. Sensorgrams of Fibronectin Binding by CshA Recombinant Domains and Control Proteins 
Representative of the binding of each CshA fragment (NR1, NR2, NR3 and R13), BSA and Fn antibody, to 
either plasma (A) or cellular (B) Fn. Note: the KD values are computationally calculated based on the exact 
amount of Fn deposited on the biosensor tip, which varies from run to run. 
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